CTLA-4 is a protein found on cytotoxic T cells of the immune system, designed to control cells and prevent them from harming normal cells, thus preventing autoimmune and allergic diseases. In cancer patients, CTLA-4 expression causes cytotoxic T cells not to act against cancer cells. For further reading, see the entry of “Immunosuppressive barrier”.
To check if our service suits your case
We need to talk
Improve therapeutic outcomes, prolong life and quality of life, are our main business.
We support access to and expand cancer treatments beyond the standard of care, with the most advanced and innovative treatment options in the world, personally matching the individual cancer patient’s medical condition and with the support of top tier oncologists.